Literature DB >> 4692143

Neurological syndromes associated with antipsychotic drug use. A special report.

D X Freedman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4692143     DOI: 10.1001/archpsyc.1973.01750340009001

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  9 in total

1.  Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.

Authors:  J Gerlach; H Simmelsgaard
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

2.  The management of neuroleptic-induced CNS effects.

Authors:  B F Hoffman; M V Seeman
Journal:  Can Fam Physician       Date:  1981-10       Impact factor: 3.275

3.  Can medication-free research ever be ethical in older people with psychotic disorders?

Authors:  Dilip V Jeste
Journal:  Schizophr Bull       Date:  2006-02-09       Impact factor: 9.306

4.  Tardive dyskinesia: age and sex differences in hospitalized schizophrenics.

Authors:  J M Smith; W T Oswald; L T Kucharski; L J Waterman
Journal:  Psychopharmacology (Berl)       Date:  1978-07-06       Impact factor: 4.530

Review 5.  A clinical guide to antipsychotic drugs.

Authors:  J T Schwartz; A W Brotman
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

6.  Movement disorders induced in monkeys by chronic haloperidol treatment.

Authors:  B Weiss; S Santelli; G Lusink
Journal:  Psychopharmacology (Berl)       Date:  1977-08-16       Impact factor: 4.530

7.  Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats.

Authors:  K Murugaiah; A Theodorou; A Clow; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Effect of baclofen on tardive dyskinesia.

Authors:  J Gerlach; T Rye; P Kristjansen
Journal:  Psychopharmacology (Berl)       Date:  1978-03-01       Impact factor: 4.530

9.  A study of prophylactic value of antiparkinsonian drug.

Authors:  P B Behere; P Ramakrishna
Journal:  Indian J Psychiatry       Date:  1983-07       Impact factor: 1.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.